Benitec Biopharma (BNTC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist

10.3314
+0.1314+1.29%

Trading Oct 3 10:06 ET

109.06MMarket Cap-1875P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Here's Why We're Not Too Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation
Simply Wall StOct 2 09:43 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
BenzingaOct 1 12:31 ET
Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc
Yahoo FinanceSep 30 21:03 ET
Benitec Biopharma Analyst Ratings
BenzingaSep 30 09:33 ET · Ratings
JMP Securities Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $16
Moomoo NewsSep 30 01:32 ET · Ratings
Buy Rating Affirmed for Benitec Biopharma on Strong Clinical Progress and Solid Financials
TipRanksSep 30 00:35 ET · Ratings

Comments

Trytosaveabit

Apr 18 19:35

News

$Benitec Biopharma (BNTC.US)$ Benitec Biopharma Inc: Bb-301 Has Been Granted Orphan Drug Designation by US FDA and EMA Committee for Orphan Medicinal Products (Comp)

GreenIsMyName

Apr 18 19:32

$Benitec Biopharma (BNTC.US)$ phase 1 :X

Trytosaveabit

Apr 18 19:31

Update

$Benitec Biopharma (BNTC.US)$ Benitec Biopharma Reports Positive Interim Clinical Trial Data for First Opmd Subject Treated With Bb-301 in Phase 1B/2a Study

Jaguar8

Apr 18 19:31

$Benitec Biopharma (BNTC.US)$
NEWS
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Positive interim clinical trial data for the first OPMD subject treated with BB-301 in a Phase 1b/2a study
Improvements in swallowing function demonstrated in multiple measures following BB-301 administration
No serious adverse events reported, with transient GERD resolved with common medications
Encouraging early clinical trial result...